Search

Your search keyword '"Suzukawa K"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Suzukawa K" Remove constraint Author: "Suzukawa K"
216 results on '"Suzukawa K"'

Search Results

1. Relationship between performance test and body composition/physical strength characteristic in sprint canoe and kayak paddlers

18. Kinom und cochleäre Spiralganglienzellen (cSGZ) – Beeinflussen Proteinkinase-Inhibitoren das Wachstum von cSGZ?

19. Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice

20. Hes1 suppresses acute myeloid leukemia development through FLT3 repression

21. Tumour necrosis factor inhibitor-associated sinusitis

31. Nerve growth factor-induced neuronal differentiation requires generation of Rac1-regulated reactive oxygen species.

37. Relapse of Acute Myeloid Leukemia with t(16;21)(p11;q22) Mimicking Autoimmune Pancreatitis after Second Allogeneic Bone Marrow Transplantation.

39. Development of navigation system employing intraoperative diffusion weighted imaging using open MRI

40. Association between adequate protein intake and quadriceps quantity and quality during rehabilitation in people with subacute stroke.

41. Relationship between progressive improvement in gait ability one year after discharge and skeletal muscle characteristics of stroke survivors.

42. Correlates of early attrition from school sports clubs in male senior high school students: a 2.4-year follow-up study.

43. Relationship between longitudinal changes in skeletal muscle characteristics over time and functional recovery during intensive rehabilitation of patients with subacute stroke.

45. Arsenite suppresses the transcriptional activity of EVI1 through the binding to CCHC-type Zn finger domain.

46. A kinase inhibitor screen identifies signaling pathways regulating mucosal growth during otitis media.

47. Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management.

48. Caloric restriction reduces basal cell proliferation and results in the deterioration of neuroepithelial regeneration following olfactotoxic mucosal damage in mouse olfactory mucosa.

49. Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62].

50. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan.

Catalog

Books, media, physical & digital resources